Iowanews Headlines

Alzheimer’s Disease Market Gearing Up for Outstanding Expansion During the Forecast Period (2023-32) | BioVie, Annovis, Eli Lilly, TauRx, Novo Nordisk, KeifeRx, AriBio, Cerecin, Alzheon, Syneos, Eisai

Alzheimer’s Disease Market Gearing Up for Outstanding Expansion During the Forecast Period (2023-32) | BioVie, Annovis, Eli Lilly, TauRx, Novo Nordisk, KeifeRx, AriBio, Cerecin, Alzheon, Syneos, Eisai

Delveinsight Business Research LLP The Alzheimer’s Disease market size in the 7MM was approximately USD 3,460.6 million in 2022 and is projected to increase during the forecast period (2023-2032). As

Read Full Article

AL Amyloidosis Market Forecasts by DelveInsight Signal Groundbreaking Growth by 2032 | Caelum Biosciences, Nexcella, HaemaLogiX, Prothena, ZENTALIS PHARMACEUTICALS, Sorrento Therapeutics

Delveinsight Business Research LLP AL Amyloidosis Market size in the seven major markets was USD 920 million in 2021. As per DelveInsight, the AL Amyloidosis Market is anticipated to evolve

Read Full Article

Head and Neck Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, “Head and Neck Cancer Pipeline Insight 2023” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Head and Neck cancer pipeline landscape. It covers the

Read Full Article

Liver Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, “Liver Cancer Pipeline Insight 2023” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the Liver Cancer pipeline drug profiles,

Read Full Article

Anaplastic Thyroid Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, “Anaplastic Thyroid Cancer Pipeline Insight 2023” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the

Read Full Article

Metastatic Castration-Resistant Prostate Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, “Metastatic Castration-Resistant Prostate Cancer Pipeline Insight 2023” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in

Read Full Article

HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, “HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Insight, 2023” report provides comprehensive insights about 5+ companies and 5+ pipeline

Read Full Article

Small Cell Lung Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in

Read Full Article

Human Papillomavirus-Positive Oropharyngeal Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsight’s, Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Insight 2023” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in

Read Full Article

Comprehensive Analysis of Neuroblastoma Pipeline in 2023: Latest Clinical Trials, FDA, EMA, and PMDA Approvals, Emerging Therapies, and Growth Potential | ORIC Pharmaceuticals, Inc., Aum Bio

Neuroblastoma Pipeline (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroblastoma pipeline constitutes 35+ key companies continuously working

Read Full Article

Categories